Skip to main content
OpenTrials
Completed

NCT Number: NCT01692613

Endomicroscopy, IBS and Food Intolerance

Background:

The immediate endoscopic identification and diagnosis of intraepithelial structures and immediate and delayed reactions to allergens in the mucosal surface of the gut are unmet goals in the diagnosis and management of subjects with food intolerances, who are negative to all available tests. Endomicroscopy may be helpful to further visualize and characterize unmasked small bowel reactions to foods, which has not been described before.

Confocal laser endomicroscopy provides confocal microscopic imaging simultaneously to the macroscopic view ,which enables the examiner to see immediate reactions after exposure and it further allows capturing of fluid excreted by the gut for further analysis to understand the pathology behind this reaction further.

N=50 patients with unexplained bloating and diarrhoea with suspicion of food intolerance and negative testing with routine methods. Patients with Lactose intolerance n=10 patients to compare results. Patients with Fructose intolerance n=10 patients to compare results. Volunteers with Barrett's esophagus who need evaluation for possible dysplasia in the Barrett's mucosa with confocal endomicrosopy but no symptoms of bloating and abdominal pain (n=10) to serve as healthy controls for allergy testing.

Methods:

The primary objective is to investigate whether endomicroscopy will allow the detection of an allergic reaction of the gut after exposure of the 5 major allergens in the following way:

After standard gastroscopy with the endomicroscope including evaluation of the surface of the upper gastrointestinal tract, i.v. injection of Fluorescein, then initial visualisation of the duodenal surface including count of initial lymphocytes/mononuclear cells in the lamina propria: Allergen 1 (milk), allergen 2 (wheat), allergen 3 (soya),allergen 4 (apple), allergen 5 (yeast).

The primary endpoint is the visible marked increase of lymphocytes and mononuclear cells in the lamina propria of the duodenum, representing an acute reaction to one of the allergens sprayed to its surface through the endoscope channel.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital Schleswig Holstein, Campus Kiel, Unit Experimental Endoscopy

Kiel, 24105, Germany

About this study

The primary endpoint is the visible marked increase of lymphocytes and mononuclear cells in the lamina propria of the duodenum, representing an acute reaction to one of the allergens sprayed to its surface through the endoscope channel.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age > 18 years
  • ongoing abdominal symptoms such as bloating and abdominal pain
  • negative routine testing for food intolerance (or known lactose/fructose intolerance)
  • written informed consent

Exclusion criteria

  • no consent
  • known reason for the abdominal pain and bloating other than lactose/fructose intolerance
  • M. Whipple
  • known infectious gastrointestinal disease
  • stricture in the upper gastrointestinal tract
  • age >18years
  • impaired renal function (Creatinine >1.2 mg/dL)
  • pregnancy or breast feeding
  • inability to obtain informed consent
  • active GI Bleeding
  • known allergy to Methylene blue or Fluorescein
  • participation in other clinical trials within the last 4 weeks

Treatment and study plan

Primary outcomes

  1. Number of mucosal reaction

    Time frame: immediate

Sponsors and collaborators

Lead sponsor

University Hospital Schleswig-Holstein

Other

Collaborators

  • Great Ormond Street Hospital for Children NHS Foundation Trust
  • Johannes Gutenberg University Mainz

Registry information

Official study title

Confocal Endomicrosopy for the Detection of Food Intolerance in Patients With Irritable Bowel Syndrome

Important dates

Study start
2012
Primary completion
2014
Study completion
2014
First posted
Sep 25, 2012
Registry last updated
Jun 3, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.